comparemela.com

Latest Breaking News On - Rastuzumab humanised monoclonal antibody - Page 1 : comparemela.com

For Retina Specialists, 2024 Is a Time to Try New Tools

This is a year for ophthalmologists to get acclimated with three blockbuster retina drugs approved in 2023, get reacclimated with a returning implant, and to brace for 2025 and beyond.

Washington
United-states
West-virginia
Illinois
American
Iveric-bio
Abbvie-allergan
Genentech-roche
Pegcetacoplan-syfovre
Reginal-sanders
Samsung-bioepis
David-boyer

Durvalumab Plus Bevacizumab Improves TACE Outcomes in HCC

A new study showed improved progression-free survival when systemic therapy is added to TACE for HCC. Overall survival outcomes are pending.

United-states
Italy
New-york
American
Josep-llovet
Riccardo-lencioni
University-of-pisa
American-society-of-clinical-oncology
American-society
Clinical-oncology
Mount-sinai-hospital
Hepatocellular-carcinoma-hcc-liver-cancer-of-the

vimarsana © 2020. All Rights Reserved.